Leaderboards/cancer immunotherapy and biomarkers

cancer immunotherapy and biomarkers

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Xianjing Chu
Central South University
99
2
Rongrong Zhou
Central South University
90
3
Jinxi Xiang
Stanford University
80
4
Ruijiang Li
Stanford Medicine
70
5
Pankaj Garg
GLA University
40
6
Shengshan Xu
Jiangmen Central Hospital
20
7
Junquan Song
Shanghai Medical College of Fudan University
10

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Shubham Pant
The University of Texas MD Anderson Cancer Center
99
2
Madeleine Benguigui
Technion – Israel Institute of Technology
90
3
Hany Abdel-Hafiz
Cedars-Sinai Medical Center
80
4
Yuming Jiang
Nanfang Hospital
60
5
C. Lyu
Zhengzhou University
50
6
Qilin Huai
Chinese Academy of Medical Sciences & Peking Union Medical College
30
7
Jia‐Wei Lv
Sun Yat-sen University
20
8
Xinan Wang
Harvard University
10

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
X. Shirley Liu
Tongji University
99
2
Luc G.T. Morris
Memorial Sloan Kettering Cancer Center
90
3
David R. Kaufman
Merck & Co., Inc., Rahway, NJ, USA (United States)
80
4
Garrett M. Frampton
Foundation Medicine (United States)
70
5
Nathan Fowler
The University of Texas MD Anderson Cancer Center
60
6
Hugo J.W.L. Aerts
Brigham and Women's Hospital
50
7
Razelle Kurzrock
University of California San Diego
40
8
Marit M. van Buuren
The Netherlands Cancer Institute
20
9
Rui‐Hua Xu
Sun Yat-sen University Cancer Center
10

All-Time Leaders Papers

1
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Genome Medicine|2017
3.7k cit.
2
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Genome biology|2016
2.8k cit.
3
Circular RNA: metabolism, functions and interactions with proteins
Molecular Cancer|2020
1.6k cit.
4
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
Molecular Cancer|2019
868 cit.
5
Epstein-Barr Virus and Cancer
Clinical Cancer Research|2004
795 cit.
6
Cistrome: an integrative platform for transcriptional regulation studies
Genome biology|2011
787 cit.
7
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
Nature Medicine|2019
710 cit.
8
Sequence determinants of improved CRISPR sgRNA design
Genome Research|2015
683 cit.
9
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
Cancer Communications|2021
653 cit.
10
LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer
Molecular Cancer|2019
543 cit.

Reagents for cancer immunotherapy and biomarkers

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Leica Biosystems

Anti-CD4 and CD8 duo pack Monoclonal Antibody, Unconjugated

Cited in 61 papers
#NCL-CD4/CD8d
View Evidence →Roche

VENTANA® anti-BRAF V600E (VE1) Mouse Monoclonal Primary Antibody

Cited in 61 papers
#760-5095 (also 08033706001)
View Evidence →Proteintech

PD-L1/CD274

Cited in 60 papers
#PCL594-FcA98166-4$250
View Evidence →

🌟 All-Time

Most validated

Proteintech

CoraLite® Plus 555-conjugated PD-1 VHH

Cited in 65 papers
#CL555-pd1$449
View Evidence →Proteintech

CoraLite® Plus 647-conjugated PD-1 VHH

Cited in 65 papers
#CL647-pd1$449
View Evidence →Proteintech

ChromoTek PD-1 VHH, recombinant binding protein for 2x Cys conjugation

Cited in 65 papers
#pd1Cys2$709
View Evidence →